Home Cart 0 Sign in  

[ CAS No. 286371-64-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 286371-64-0
Chemical Structure| 286371-64-0
Structure of 286371-64-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 286371-64-0 ]

Related Doc. of [ 286371-64-0 ]

Alternatived Products of [ 286371-64-0 ]

Product Details of [ 286371-64-0 ]

CAS No. :286371-64-0 MDL No. :MFCD13185883
Formula : C16H14N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :UEDIEWQHFJNDTF-UHFFFAOYSA-N
M.W : 282.29 Pubchem ID :135497017
Synonyms :

Calculated chemistry of [ 286371-64-0 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 16
Fraction Csp3 : 0.12
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 79.83
TPSA : 64.21 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.99
Log Po/w (XLOGP3) : 2.14
Log Po/w (WLOGP) : 2.36
Log Po/w (MLOGP) : 1.99
Log Po/w (SILICOS-IT) : 3.49
Consensus Log Po/w : 2.39

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.24
Solubility : 0.163 mg/ml ; 0.000578 mol/l
Class : Soluble
Log S (Ali) : -3.12
Solubility : 0.214 mg/ml ; 0.000758 mol/l
Class : Soluble
Log S (SILICOS-IT) : -6.02
Solubility : 0.000268 mg/ml ; 0.000000951 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.26

Safety of [ 286371-64-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 286371-64-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 286371-64-0 ]
  • Downstream synthetic route of [ 286371-64-0 ]

[ 286371-64-0 ] Synthesis Path-Upstream   1~22

  • 1
  • [ 909912-09-0 ]
  • [ 3473-63-0 ]
  • [ 286371-64-0 ]
YieldReaction ConditionsOperation in experiment
94%
Stage #1: at 130℃; for 24 h;
Stage #2: With ammonia In 2-methoxy-ethanol; water at 20℃;
6-(benzyloxy)-7-methoxyquinazolin-4(3H)-one: Preparation 9 (5 g,18.3 mmol) was mixed with amidine acetate (3.8 g, 36.6 mmol) in ethylene glycol monomethyl ether (25 mL) and the mixture was heated at 13O0C for 24 h. After cooling to room temperature, part of the solvent was removed in vacuo and ammonium hydroxide (5 mL, 30percent in water) and water (50 mL) were added. The solid was filtered, was washed with water and hexanes, and was then dried under vacuum to afford 4.87 g (94percent yield) of the title compound; MS (AP/CI): 283.1 (M+H)+ .
Reference: [1] Patent: WO2008/20302, 2008, A2, . Location in patent: Page/Page column 29
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
  • 2
  • [ 1494468-50-6 ]
  • [ 286371-64-0 ]
YieldReaction ConditionsOperation in experiment
88% With peracetic acid; sulfuric acid In ethanol at 60℃; for 10 h; General procedure: To a solution of 6,7-dimethoxyquinazoline 1a (200.0 mg, 1.05 mmol) in ethanol (20 mL) were added 40percent peracetic acid (1.0mL, 5.26 mmol) and 0.01 mL sulfuric acid (1.8 mmol). After the reaction was stirred at 60°C for 4–12 h (see Table 2) and then cooled to room temperature, excess sodium bisulfite (541.8 mg, 5.26 mmol) was added to get rid of the peroxide. The solid was filtered off after stirring for 20 min, and the filtrate was concentrated under reduced pressure to give the crude product, which was washed by ethanol and petroleum ether to give 2a as a light yellow solid (179.7 mg, 83percent), mp>300°C.
Reference: [1] Synthetic Communications, 2014, vol. 44, # 3, p. 346 - 351
  • 3
  • [ 855793-63-4 ]
  • [ 164161-49-3 ]
  • [ 286371-64-0 ]
Reference: [1] Patent: EP1153920, 2001, A1,
  • 4
  • [ 77287-34-4 ]
  • [ 634197-80-1 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 23, p. 4910 - 4925
  • 5
  • [ 855793-63-4 ]
  • [ 3473-63-0 ]
  • [ 286371-64-0 ]
YieldReaction ConditionsOperation in experiment
38.4 g for 12 h; Reflux A mixture of iron powder (29 g, 0.527 mol) and acetic acid 270 mL was stirred and heated to 50-60°C till a grey white suspension was formed. The suspension was diluted with 150 mL methanol. Methyl 4-methoxy-3-benzyloxy-6-nitrobenzoate 7 (50g, 0.1575 mol) was added portion wise at regular intervals. The reaction was maintained at the same temperature for 5-6 hr. The mixture was filtered hot and the filtrate was evaporated to a residue mass under reduced pressure. The residue was extracted with ethyl acetate 2 × 300 mL. The combined organic layers were washed with water* and formamidine acetate 28.6 g (0.2747 mol) was added to the organic layer and refluxed for 12 hr. Reaction mass was cooled to 25-30°C and stirred for 1 hr and precipitated solid was collected by filtration. Isolated solid was slurry washed with 250 mL methanol and dried to get the off white powder 9, 38.4 g (yield 91percent, purity 98percent); m.p. 258-60°C; 1HNMR (DMSO-d6, 300 MHz): 12.076 (s, 1H), 7.986 (s, 1H), 7.342-7.545 (m, 6H), 7.152 (s, 1H), 5.206 (s, 2H), 3.913 (s, 3H); MS (EI): m/z 283 (M + 1).
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53B, # 10, p. 1269 - 1274
  • 6
  • [ 645-08-9 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 23, p. 4910 - 4925
[2] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53B, # 10, p. 1269 - 1274
  • 7
  • [ 634198-01-9 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 23, p. 4910 - 4925
[2] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
  • 8
  • [ 148235-40-9 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 23, p. 4910 - 4925
  • 9
  • [ 122-51-0 ]
  • [ 60547-95-7 ]
  • [ 286371-64-0 ]
Reference: [1] Patent: US2007/167470, 2007, A1, . Location in patent: Page/Page column 10-11
  • 10
  • [ 164161-49-3 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
[2] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53B, # 10, p. 1269 - 1274
  • 11
  • [ 31839-20-0 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
[2] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
  • 12
  • [ 215659-03-3 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
  • 13
  • [ 855793-63-4 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
  • 14
  • [ 4998-07-6 ]
  • [ 286371-64-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4536 - 4547
  • 15
  • [ 6346-05-0 ]
  • [ 286371-64-0 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 3, p. 346 - 351
  • 16
  • [ 58662-50-3 ]
  • [ 286371-64-0 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 3, p. 346 - 351
  • 17
  • [ 1042978-66-4 ]
  • [ 286371-64-0 ]
Reference: [1] Synthetic Communications, 2014, vol. 44, # 3, p. 346 - 351
  • 18
  • [ 26791-93-5 ]
  • [ 286371-64-0 ]
Reference: [1] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
  • 19
  • [ 621-59-0 ]
  • [ 286371-64-0 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53B, # 10, p. 1269 - 1274
  • 20
  • [ 6702-50-7 ]
  • [ 286371-64-0 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53B, # 10, p. 1269 - 1274
  • 21
  • [ 57535-57-6 ]
  • [ 286371-64-0 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2014, vol. 53B, # 10, p. 1269 - 1274
  • 22
  • [ 122-51-0 ]
  • [ 634197-80-1 ]
  • [ 286371-64-0 ]
Reference: [1] ChemMedChem, 2014, vol. 9, # 7, p. 1476 - 1487
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 286371-64-0 ]

Aryls

Chemical Structure| 92855-64-6

[ 92855-64-6 ]

6-Benzyloxyindole-3-carbaldehyde

Similarity: 0.66

Chemical Structure| 6953-22-6

[ 6953-22-6 ]

5-Benzyloxyindole-3-carboxaldehyde

Similarity: 0.66

Chemical Structure| 62553-86-0

[ 62553-86-0 ]

3-Hydroxy-N-(3-methoxyphenyl)-2-naphthamide

Similarity: 0.64

Chemical Structure| 1168150-46-6

[ 1168150-46-6 ]

(E)-Methyl 3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

Similarity: 0.63

Chemical Structure| 7042-71-9

[ 7042-71-9 ]

4-Benzyloxyindole-3-carbaldehyde

Similarity: 0.63

Ethers

Chemical Structure| 162012-72-8

[ 162012-72-8 ]

6-Methoxy-7-hydroxyquinazolin-4-one

Similarity: 0.94

Chemical Structure| 179688-52-9

[ 179688-52-9 ]

6-Hydroxy-7-methoxyquinazolin-4(1H)-one

Similarity: 0.94

Chemical Structure| 13794-72-4

[ 13794-72-4 ]

6,7-Dimethoxy-1H-quinazolin-4-one

Similarity: 0.94

Chemical Structure| 16064-24-7

[ 16064-24-7 ]

7-Methoxyquinazolin-4(1H)-one

Similarity: 0.90

Chemical Structure| 179688-53-0

[ 179688-53-0 ]

7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate

Similarity: 0.77

Amides

Chemical Structure| 162012-72-8

[ 162012-72-8 ]

6-Methoxy-7-hydroxyquinazolin-4-one

Similarity: 0.94

Chemical Structure| 179688-52-9

[ 179688-52-9 ]

6-Hydroxy-7-methoxyquinazolin-4(1H)-one

Similarity: 0.94

Chemical Structure| 13794-72-4

[ 13794-72-4 ]

6,7-Dimethoxy-1H-quinazolin-4-one

Similarity: 0.94

Chemical Structure| 16064-24-7

[ 16064-24-7 ]

7-Methoxyquinazolin-4(1H)-one

Similarity: 0.90

Chemical Structure| 179688-53-0

[ 179688-53-0 ]

7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate

Similarity: 0.77

Related Parent Nucleus of
[ 286371-64-0 ]

Quinazolines

Chemical Structure| 162012-72-8

[ 162012-72-8 ]

6-Methoxy-7-hydroxyquinazolin-4-one

Similarity: 0.94

Chemical Structure| 179688-52-9

[ 179688-52-9 ]

6-Hydroxy-7-methoxyquinazolin-4(1H)-one

Similarity: 0.94

Chemical Structure| 13794-72-4

[ 13794-72-4 ]

6,7-Dimethoxy-1H-quinazolin-4-one

Similarity: 0.94

Chemical Structure| 16064-24-7

[ 16064-24-7 ]

7-Methoxyquinazolin-4(1H)-one

Similarity: 0.90

Chemical Structure| 179688-53-0

[ 179688-53-0 ]

7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate

Similarity: 0.77